Novartis to License Drug From China’s Abogen in Up to $7.8 Billion Deal – WSJ
Novartis has sealed several tie-ups with emerging Chinese biotech players in recent years. Novartis is paying $575 million upfront and could makeĀ …Read More
Novartis has sealed several tie-ups with emerging Chinese biotech players in recent years. Novartis is paying $575 million upfront and could makeĀ …Read More
by Newsbot · Published October 2, 2026
by Newsbot · Published October 2, 2026
by Newsbot · Published October 2, 2026
by Newsbot · Published October 2, 2026
by Newsbot · Published October 1, 2026
by Newsbot · Published October 1, 2026
by Newsbot · Published October 1, 2026
by Newsbot · Published October 1, 2026
by Newsbot · Published October 1, 2026
by Newsbot · Published September 30, 2026
